Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.07 -0.24 (-3.35%)
As of: Oct 21, 2026 · 3:39 PM EDT

Phathom Pharmaceuticals (PHAT) Notes Payables (2018 - 2019)

Updated

Phathom Pharmaceuticals (PHAT) reported Notes Payables of $95.23 million for Q3 2019.

Analysis

Phathom Pharmaceuticals (PHAT) Notes Payables (2018 - 2019) Analysis & Trends

At the end of FY2018, Phathom Pharmaceuticals posted Notes Payables of $1.95 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 Phathom Pharmaceuticals 592.51 Mn -47.45 Mn 59.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 95.23 Mn
Dec 31, 2018 1.95 Mn
API Access

Phathom Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=PHAT&period=max&api_key=YOUR_API_KEY